First-Line Radio-Immunotherapy of Newly Diagnosed, Advanced Follicular Non-Hodgkin Lymphoma with 131I-Rituximab: The INITIAL Study

被引：0
|
作者：
McQuillan, Andrew D. [1 ]
Macdonald, William B. G. [1 ]
Leahy, Michael F. [1 ]
Turner, J. Harvey [1 ]
机构：
[1] Fremantle Hosp, Fremantle, WA, Australia
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1589 / 1589
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF FIRST-LINE I-131-RITUXIMAB RADIOIMMUNOTHERAPY OF FOLLICULAR NON-HODGKIN LYMPHOMA: THE INITIAL STUDY
    Macdonald, W.
    McQuillan, A.
    Turner, J. H.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 16 - 17
  • [2] Rituximab maintenance versus radio-immunotherapy consolidation in first remission follicular non-Hodgkin lymphoma
    Hagenbeek, A.
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (01) : 43 - 43
  • [3] Radioimmunotherapy of newly diagnosed, advanced, low-grade lymphoma with 131I-rituximab:: The initial study
    McQuillan, A. D.
    Macdonald, W. B.
    Leahy, M. F.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 207 - 207
  • [4] Outpatient 131I-Rituximab Radioimmunotherapy for Non-Hodgkin Lymphoma A Study in Safety
    Calais, Phillipe J.
    Turner, John Harvey
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (08) : 732 - 737
  • [5] Safety of 131I-Rituximab Outpatient Radioimmunotherapy of Non-Hodgkin Lymphoma
    Calais, P. J.
    Turner, J. H.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [6] Phase II study of first-line 131I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic 18F-fluorodeoxyglucose positron emission tomography
    McQuillan, Andrew D.
    Macdonald, William B. G.
    Turner, J. Harvey
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1271 - 1277
  • [7] Clinical scale preparation and evaluation of 131I-Rituximab for Non-Hodgkin's Lymphoma
    Kameswaran, Mythili
    Vimalnath, K. Viswanathan
    Rajeswari, Ardhi
    Joshi, Prahlad Vasudeo
    Sarma, H. D.
    Samuel, Grace
    RADIOCHIMICA ACTA, 2014, 102 (06) : 553 - 560
  • [8] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience
    Maren Bienert
    Ingrid Reisinger
    Stefanie Srock
    Beatrice I Humplik
    Christel Reim
    Thomas Kroessin
    Norbert Avril
    Antonio Pezzutto
    Dieter L Munz
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1225 - 1233
  • [9] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma:: initial experience
    Bienert, M
    Reisinger, I
    Srock, S
    Humplik, BI
    Reim, C
    Kroessin, T
    Avril, N
    Pezzutto, A
    Munz, DL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1225 - 1233
  • [10] RADIO-IMMUNOTHERAPY CONSOLIDATION VERSUS RITUXIMAB-MAINTENANCE IN FIRST REMISSION FOLLICULAR NON-HODGKIN'S LYMPHOMA. THE CASE FOR RIT.
    Hagenbeek, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 81 - 81
12345